Indications and effects of botulinum toxin A for obstetric brachial plexus injury: A systematic literature review

Developmental Medicine and Child Neurology

Volumn 52, Issue 6, 2010, Pages 517-528

  Gobets, David ^a   Beckerman, Heleen ^a   Groot, Vincent De ^a   Van Doorn Loogman, Miriam H ^a   Becher, Jules G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADDUCTION; BRACHIAL PLEXUS INJURY; CINAHL; COCHRANE LIBRARY; DRUG EFFICACY; DRUG INDICATION; DRUG USE; ELBOW FLEXION; EMBASE; HUMAN; INFORMATION RETRIEVAL; JOINT CONTRACTURE; JOINT MOBILITY; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

BIRTH INJURIES; BOTULINUM TOXIN TYPE A; BRACHIAL PLEXUS NEUROPATHIES; FEMALE; HUMANS; NEUROMUSCULAR AGENTS; PREGNANCY;

EID: 77953927182     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2009.03607.x     Document Type: Review

References (43)

1. Foad SL, Mehiman CT, Ying J. The epidemiology of neonatal brachial plexus palsy in the United States. J Bone Joint Surg Am 2008, 90:1258-64.
2. Backe B, Magnussen EB, Johansen OJ, Sellaeg G, Russwurm H. Obstetric brachial plexus palsy: a birth injury not explained by the known risk factors. Acta Obstet Gynecol Scand 2008, 87:1027-32.
3. Mollberg M, Wennergren M, Bager B, Ladfors L, Hagberg H. Obstetric brachial plexus palsy: a prospective study on risk factors related to manual assistance during the second stage of labor. Acta Obstet Gynecol Scand 2007, 86:198-204.
4. Hoeksma AF, Wolf H, Oei SL. Obstetric brachial plexus injuries: incidence, natural course and shoulder contracture. Clin Rehabil 2000, 14:523-6.
5. Waters PM. Update on management of pediatric brachial plexus palsy. J Pediatr Orthop B 2005, 14:233-44.
6. Hoeksma AF, ter Steeg AM, Nelissen RG, van Ouwerkerk WJR, Lankhorst GJ, de Jong BA. Neurological recovery in obstetrical brachial plexus injuries: an historical cohort study. Dev Med Child Neurol 2004, 46:76-83.
7. Bennet GC, Harrold AJ. Prognosis and early management of birth injuries to the brachial plexus. BMJ 1976, 1:1520-1.
8. Hardy AE. Birth injuries of the brachial plexus: incidence and prognosis. J Bone Joint Surg Br 1981, 63B:98-101.
9. Michelow BJ, Clarke HM, Curtis CG, Zuker RM, Seifu Y, Andrews DF. The natural history of obstetrical brachial plexus palsy. Plast Reconstr Surg 1994, 93:675-80.
10. Slooff AC. Obstetric brachial plexus lesions and their neurosurgical treatment. Clin Neurol Neurosurg 1993, 95:73-7.
11. Jost WH. Other indications of botulinum toxin therapy. Eur J Neurol 2006, 13(Suppl. 1):65-9.
12. van Dijk JG. Botulinum toxin and the pathophysiology of obstetric brachial plexus lesions. Dev Med Child Neurol 2007, 49:318-20.
13. Boeschoten K, Folmer K, van der Lee JH, Nollet F. Development of a set of activities to evaluate the arm and hand function in children with obstetric brachial plexus lesion. Clin Rehabil 2007, 21:163-70.
14. International Classification of Functioning, Disability and Health. Non-serial publication edn 2001, Geneva, WHO
15. Lefebvre C, Manheimer E, Glanville J. Searching for studies. Cochrane Handbook for Systematic Reviews of Interventions 2008, 136-139. Higgins JPT, Green S, editors, Chichester, UK, The Cochrane Collaboration
16. Brettle A, Grant MJ. Finding the Evidence for Practice: A Workbook for Health Professionals 2004, Edinburgh, Churchill Livingstone
17. Basciani M, Intiso D. Botulinum toxin and plaster cast treatment in child with mild upper brachial palsy. Arch Pharmacol 2002, 365:R14.
18. Basciani M, Intiso D. Botulinum toxin type-A and plaster cast treatment in children with upper brachial plexus palsy. Pediatr Rehabil 2006, 9:165-70.
19. DeMatteo C, Bain JR, Galea V, Gjertsen D. Botulinum toxin as an adjunct to motor learning therapy and surgery for obstetrical brachial plexus injury. Dev Med Child Neurol 2006, 48:245-52.
20. Desiato MT, Risina B. The role of botulinum toxin in the neuro-rehabilitation of young patients with brachial plexus birth palsy. Pediatr Rehabil 2001, 4:29-36.
21. Grossman JA, Price AE, Tidwell MA, Ramos LE, Alfonso I, Yaylali I. Outcome after later combined brachial plexus and shoulder surgery after birth trauma. J Bone Joint Surg Br 2003, 85B:1166-8.
22. Grossman JA, DiTaranto P, Yaylali I, Alfonso I, Ramos LE, Price AE. Shoulder function following late neurolysis and bypass grafting for upper brachial plexus birth injuries. J Hand Surg [Br] 2004, 29:356-8.
23. Heise CO, Gonçalves LR, Barbosa ER, Gherpelli JL. Botulinum toxin for treatment of co-contractions related to obstetrical brachial plexopathy. Arq Neuropsiquiatr 2005, 63:588-91.
24. Hierner R, Rollnik JD, Berger AC, Dengler R. Botulinum toxin type a for the treatment of biceps/triceps co-contraction in obstetrical brachial plexus lesions - preliminary results after a follow-up of 18 months. Eur J Plast Surg 2001, 24:2-6.
25. Johnstone BR, McCombe D, Coombs C, Britt K. Botulinum toxin in obstetric brachial plexus palsy. ANZ J Surg 2007, 77(Suppl. 1):A34-6.
26. Michaud LJ, Mehlman CT, Foad SL, Yakuboff KP. Use of botulinum toxin type a in birth brachial plexus palsy: a case series. Arch Phys Med Rehabil 2007, 88:E81-2.
27. Price AE, DiTaranto P, Yaylali I, Valencia H, Tidwell MA, Grossman JA. The use of botulinum toxin type A as a surgical adjunct in the management of the brachial plexus birth trauma. POSNA meeting 2005, paper No. 62
28. Price AE, DiTaranto P, Yaylali I, Tidwell MA, Grossman JA. Botulinum toxin type A as an adjunct to the surgical treatment of the medial rotation deformity of the shoulder in birth injuries of the brachial plexus. J Bone Joint Surg Br 2007, 89:327-9.
29. Rollnik JD, Hierner R, Schubert M. Botulinum toxin treatment of co-contractions after birth-related brachial plexus lesions. Neurology 2000, 55:112-4.
30. Schubert M, Wohlfarth K, Hierner R. Botulinum toxin type A in obstetrical brachial plexus lesions. Electroencephalogr Clin Neurophysiol 1998, 107:70-1.
31. Stanton JS, Bainbridge LC. The use of botulinum toxin for the internal rotation contracture of the shoulder in obstetric brachial plexus palsy. Arch Pharmacol 2002, 365(Suppl. 2):R44.
32. Grossman JA, DiTaranto P, Price AE, Ramos LE, Tidwell M, Papazian O. Multidisciplinary management of brachial plexus birth injuries: the Miami experience. Semin Plast Surg 2004, 18:319-26.
33. van der Sluijs JA, Doorn-Loogman MH, Ritt MJ, Wuisman PI. Interobserver reliability of the Mallet score. J Pediatr Orthop B 2006, 15:324-7.
34. Liberati A, Altman DG, Tetzlaff J. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009, 62:e1-34.
35. Reeuwijk A, van Schie PE, Becher JG, Kwakkel G. Effects of botulinum toxin type A on upper limb function in children with cerebral palsy: a systematic review. Clin Rehabil 2006, 20:375-87.
36. Brown T, Cupido C, Scarfone H, Pape K, Galea V, McComas A. Developmental apraxia arising from neonatal brachial plexus palsy. Neurology 2000, 55:24-30.
37. Currà A, Trompetto C, Abbruzzese G, Berardelli A. Central effects of botulinum toxin type A: evidence and supposition. Mov Disord 2004, 19(Suppl. 8):S60-4.
38. van Dijk JG, Pondaag W, Malessy MJ. Obstetric lesions of the brachial plexus. Muscle Nerve 2001, 24:1451-61.
39. Gracies JM, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity. Part I: local treatments. Muscle Nerve Suppl 1997, 6:61-91.
40. Kawamura A, Campbell K, Lam-Damji S, Fehlings D. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity. Dev Med Child Neurol 2007, 49:331-7.
41. Graham HK, Aoki KR, Autti-Rämö I. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000, 11:67-79.
42. Russman BS, Tilton A, Gormley ME. Cerebral palsy: a rational approach to a treatment protocol and the role of botulinum toxin in treatment. Muscle Nerve Suppl 1997, 6:181-93.
43. Bakheit AM, Severa S, Cosgrove A. Safety profile and efficacy of botulinum toxin A (Dysport) in children with muscle spasticity. Dev Med Child Neurol 2001, 43:234-8.